(Left to right) Lawrence Tallon, chief executive of the Medicines and Healthcare products Regulatory Agency, Professor Alastair Denniston, head of the UK’s Centre of Excellence in Regulatory Science in AI & Digital Health, and…
Continue Reading
Houdini Abtahi, National Healthcare Lead at Resultant
What if the biggest threat to AI implementation in healthcare isn’t regulation or funding, but impatience?
According to IBM’s recent CEO survey, only 25% of AI initiatives have delivered…
Continue Reading
Lawrence Tallon, chief executive at the Medicines and Healthcare products Regulatory Agency (Credit: MHRA)
A new national commission which includes experts from Google and Microsoft will help to accelerate access to AI ambient voice…
Continue Reading
FDA Advisory Committee Meeting Overview
The Food and Drug Administration (FDA) is taking a significant step forward in evaluating artificial intelligence applications in healthcare by convening its Digital Health Advisory Committee on November 6, 2024….
Ana Ponder, Director of RCM Solutions at Millennia
The medical debt regulation landscape is poised to change drastically over the next few years. Laws in Texas, New York, and New Jersey are key case studies…
Continue Reading
UK and Netherlands-based cyber security and compliance firm Naq has raised €6 million (£5.1m) to help health technology companies meet NHS standards.
The startup, which emerged from the government’s National Cyber Security Centre flagship cyber…
"We were on the floor." Michele Goodman explains how they built trust in the new automated processes at Saint Peter's University Hospital. 👏See how they're freeing up staff for patient care: https://www.healthcareittoday.com/2025/06/05/easing-regulation-through-workflow-and-automation-by-amitech/#AmitechSolution #SaintPetersUniversityHospital #RPA…
Continue Reading
Background: Research about the engagement of adolescents with mobile health (mHealth) interventions is scarce, while it is generally assumed that the engagement affects the intervention efficacy. Objective: Using a mHealth intervention that targets the…
Continue Reading
Depressed mood and anhedonia, the core symptoms of major depressive disorder (MDD), are linked to dysfunction in the brain’s reward and emotion regulation circuits. To develop a predictive model for treatment remission in MDD…
Continue Reading
Lawrence Tallon, chief executive at the Medicines and Healthcare products Regulatory Agency (Credit: MHRA)
Manufacturers will be able to supply innovative medical devices to the NHS use before obtaining full regulatory approval, under new…
Continue Reading
